Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Touchstar (TST) by Steve Moore in ShareProphets
- Outperform Pagegroup (PAGE) by RBC Capital
- Neutral Dunelm Group (DNLM) by JP Morgan
- Equal Weight ASOS (ASC) by Barclays
- Overweight Team17 Group (TM17) by Barclays
- Hold Diageo (DGE) by Jefferies
- Hold ASOS (ASC) by Jefferies
- Buy Hunting (HTG) by Jefferies
- Overweight Spire Healthcare Group (SPI) by JP Morgan
- Overweight Flutter Entertainment (DI) (FLTR) by JP Morgan
- Hold Dunelm Group (DNLM) by Jefferies
- Buy Rentokil Initial (RTO) by Jefferies
- Buy BHP Group Limited NPV (DI) (BHP) by Jefferies
- Buy Deliveroo Class (ROO) by Jefferies
- Buy Experian (EXPN) by Jefferies
- Hold Reckitt Benckiser Group (RKT) by HSBC
- Avoid Inspects Group (SPEC) by Steve Moore in ShareProphets
- Add YouGov (YOU) by Ben McPoland in The Motley Fool
- Buy WPP (WPP) by Shore Capital
- Buy Associated British Foods (ABF) by Shore Capital
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 14 open tips for Physiomics (PYC)
| Latest Bid : 1.10p | Latest Ask : 1.20p |
| High Today : 1.15p | Low Today : 1.11p |
| This Years High : 3.15p | This Years Low : 0.95p |
| Volume : 171,930 | MKT Cap : £1.55M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 11.54% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 23.33% |
| Avoid | Steve Moore | Premium Only | 2023-09-01 16:10:00 01/09/2023 | 28.13% |
| Avoid | Steve Moore | Premium Only | 2023-08-04 16:00:00 04/08/2023 | -21.05% |
| Avoid | Steve Moore | Premium Only | 2023-06-27 11:10:00 27/06/2023 | -15.00% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1.10p | Latest Ask : 1.20p |
| High Today : 1.15p | Low Today : 1.11p |
| This Years High : 3.15p | This Years Low : 0.95p |
| Volume : 171,930 | MKT Cap : £1.55M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2024-03-07 16:20:00 07/03/2024 | 11.54% |
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | 23.33% |
| Avoid | Steve Moore | Premium Only | 2023-09-01 16:10:00 01/09/2023 | 28.13% |
| Avoid | Steve Moore | Premium Only | 2023-08-04 16:00:00 04/08/2023 | -21.05% |
| Avoid | Steve Moore | Premium Only | 2023-06-27 11:10:00 27/06/2023 | -15.00% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000